
West End Drugs Private Limited
About West End Drugs Private Limited
Data last updated:
West End Drugs Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 14 July 2009.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2009PTC194045. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Sunil Kumar Sahoo (Managing Director) and Hirak Kumar Parmanik.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at 405 Jasmine Natasha Park, Mumbai, Maharashtra.
As per the financials filed for FY 2016, the company reported a revenue of ₹24.58 Lakh, a decline of 36% compared to the previous year. For the same year it recorded a net loss of ₹4.62 Lakh (net margin -18.8%) and EBITDA of -₹4.6 Lakh (EBITDA margin -18.7%).
Company details
Contact details
West End Drugs Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressFlat No. B – 405 Jasmine Natasha Park – 1 Cooperative Housing Society Mira Road (, E), Mumbai, Maharashtra, India – 401107
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of West End Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of West End Drugs Private Limited, buy the company report.
Financials of West End Drugs Private Limited
FY 2016 filings availableWest End Drugs Private Limited reported revenue of ₹24.58 Lakh (down 36% YoY) for FY 2016.
Compounded Annual Growth Rate (CAGR)
Revenue fell 36% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹4.6 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹4.62 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -18.7% | |
| Net Profit Margin | -18.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of West End Drugs Private Limited, buy the company report.
Board of directors of West End Drugs Private Limited
West End Drugs has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hirak Kumar Parmanik | Director | 03 Oct 2009 | 17 Years 1 Months | As last reported |
| Sunil Kumar Sahoo | Managing Director | 14 Jul 2009 | 17 Years 4 Months | As last reported |
| Narayan Prasad Jena | Additional Director | 20 Nov 2009 | 16 Years 11 Months | As last reported |
| Anuswuya Sarangi | Additional Director | 20 Nov 2009 | 16 Years 11 Months | As last reported |
Peer comparison
West End Drugs Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Geeta Gems & Jewellers Private Limited | ₹24.59 Lakh (FY 2024) | -4.0% | Kolkata, West Bengal, India | |||
| Eco Grey Private Limited | ₹24.59 Lakh (FY 2023) | Nagpur, Maharashtra, India | ||||
| Afterlink Vyapaar Private Limited | ₹24.59 Lakh (FY 2025) | -58.0% | Kolkata, West Bengal, India | |||
| Topx Greentech (India) Private Limited | ₹24.59 Lakh (FY 2022) | 2973.0% | Navi Mumbai, Maharashtra, India | |||
| Adorn Cosmetics Private Limited | ₹24.58 Lakh (FY 2025) | -42.0% | Samastipur, Bihar, India | |||
| West End Drugs Private Limitedthis company | ₹24.58 Lakh (FY 2016) | -₹4.62 Lakh | -18.8% | -36.0% | Mumbai, Maharashtra, India | |
| Akumarine Nutrition Health Care Private Limited | ₹24.58 Lakh (FY 2022) | Mumbai, Maharashtra, India | ||||
| Nakasu International Private Limited | ₹24.57 Lakh (FY 2024) | -31.0% | Delhi, India | |||
| Rashe Lifesciences Private Limited | ₹24.57 Lakh (FY 2022) | 339.0% | Bangalore, Karnataka, India | |||
| Dsgi Creations Private Limited | ₹24.57 Lakh (FY 2024) | 30.0% | Agra, Uttar Pradesh, India | |||
| Zyma Meitei Thokchom (ZMT) Private Limited | ₹24.57 Lakh (FY 2024) | 238.0% | Ukhrul, Manipur, India |
To see the full peer comparison of West End Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving West End Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for West End Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
West End Drugs has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of West End Drugs Private Limited, buy the company report.
Recent activity
West End Drugs Private Limited has 5 board changes on record since 2009: 4 appointments and 1 cessation. The latest: Abani Kumar Tripathy ceased to be Director on 20 Nov 2009.
Frequently asked questions
West End Drugs has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
West End Drugs was a private limited company based in Mumbai, Maharashtra, India. The company worked in wholesale, within the trading industry. It was incorporated on 14 July 2009 and is registered under CIN U24239MH2009PTC194045. The company has been struck off by the Registrar of Companies and is no longer operational.
West End Drugs had 4 directors:
- Sunil Kumar Sahoo - Managing Director
- Hirak Kumar Parmanik - Director
- Narayan Prasad Jena - Additional Director
- Anuswuya Sarangi - Additional Director
The CIN (Corporate Identification Number) of West End Drugs is U24239MH2009PTC194045. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of West End Drugs is at Flat No. B – 405 Jasmine Natasha Park – 1 Cooperative Housing Society Mira Road , E, Mumbai, Maharashtra, India – 401107.
West End Drugs was incorporated on 14 July 2009. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of West End Drugs on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from 2015 are in the company report.
No. West End Drugs has 1 GST registration on record and it is cancelled or inactive.
West End Drugs operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.
The peers of West End Drugs by revenue are Geeta Gems & Jewellers Private Limited, Eco Grey Private Limited, Afterlink Vyapaar Private Limited, Topx Greentech (India) Private Limited, Adorn Cosmetics Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Abani Kumar Tripathy ceased to be Director on 20 Nov 2009. Anuswuya Sarangi was appointed as Additional Director on 20 Nov 2009. Narayan Prasad Jena was appointed as Additional Director on 20 Nov 2009. West End Drugs has 5 board changes on record in total.

